| COVID-19: Pathogenesis of a multi-faceted disease V Bonny, A Maillard, C Mousseaux, L Plaçais, Q Richier La Revue de medecine interne 41 (6), 375-389, 2020 | 181* | 2020 |
| Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients A Maillard, R Redjoul, M Klemencie, H Labussière Wallet, A Le Bourgeois, ... Blood, The Journal of the American Society of Hematology 139 (1), 134-137, 2022 | 75* | 2022 |
| Hesitancy towards COVID-19 vaccination among healthcare workers: a multi-centric survey in France C Janssen, A Maillard, C Bodelet, AL Claudel, J Gaillat, T Delory, ... Vaccines 9 (6), 547, 2021 | 51 | 2021 |
| Impaired decision making and loss of inhibitory-control in a rat model of Huntington disease N El Massioui, C Lamirault, S Yagüe, N Adjeroud, D Garces, A Maillard, ... Frontiers in Behavioral Neuroscience 10, 204, 2016 | 22 | 2016 |
| Blockbuster effect of COVID-19 on the impact factor of infectious disease journals A Maillard, T Delory Clinical Microbiology and Infection 28 (12), 1536-1538, 2022 | 19 | 2022 |
| Effectiveness of third-generation cephalosporins or piperacillin compared with cefepime or carbapenems for severe infections caused by wild-type AmpC β-lactamase-producing … A Maillard, T Delory, J Bernier, A Villa, K Chaibi, L Escaut, A Contejean, ... International Journal of Antimicrobial Agents 62 (1), 106809, 2023 | 16 | 2023 |
| Outbreaks of COVID-19 in nursing homes: a cross-sectional survey of 74 nursing homes in a French area E Piet, A Maillard, FO Mallaval, JY Dusseau, M Galas-Haddad, S Ducki, ... Journal of Clinical Medicine 10 (18), 4280, 2021 | 16 | 2021 |
| Can chatbot artificial intelligence replace infectious diseases physicians in the management of bloodstream infections? A prospective cohort study A Maillard, G Micheli, L Lefevre, C Guyonnet, C Poyart, E Canouï, ... Clinical Infectious Diseases 78 (4), 825-832, 2024 | 15 | 2024 |
| Safety and efficacy of fumagillin for the treatment of intestinal microsporidiosis. A French prospective cohort study A Maillard, A Scemla, B Laffy, N Mahloul, JM Molina Journal of Antimicrobial Chemotherapy 76 (2), 487-494, 2021 | 15 | 2021 |
| Effect of professional and extra-professional exposure on seroprevalence of SARS-CoV-2 infection among healthcare workers of the French Alps: a multicentric cross-sectional study V Vitrat, A Maillard, A Raybaud, C Wackenheim, B Chanzy, S Nguyen, ... Vaccines 9 (8), 824, 2021 | 12 | 2021 |
| Advances in antibacterial treatment of adults with high-risk febrile neutropenia A Contejean, A Maillard, E Canouï, S Kernéis, B Fantin, D Bouscary, ... Journal of Antimicrobial Chemotherapy 78 (9), 2109-2120, 2023 | 6 | 2023 |
| Dual beta-lactam treatment: Pros and cons D Guerra, P Vidal, O Paccoud, A Maillard, L Cachera, H Junot, R Gauzit, ... Porto Biomedical Journal 7 (5), e189, 2022 | 4 | 2022 |
| Mutation Rate of AmpC β-Lactamase–Producing Enterobacterales and Treatment in Clinical Practice: A Word of Caution A Maillard, L Dortet, T Delory, M Lafaurie, A Bleibtreu Clinical Infectious Diseases, ciae160, 2024 | 3 | 2024 |
| Fluoroquinolones in primary care, a first step for patient empowerment towards antimicrobial stewardship? A Maillard, P Jeanmougin, E Bouvet, S Lariven, J Le Bel, T Delory Clinical Microbiology and Infection 30 (1), 7-9, 2024 | 3 | 2024 |
| Appropriateness of intended antibiotic prescribing using clinical case vignettes in primary care, and related factors T Delory, A Maillard, F Tubach, PY Böelle, E Bouvet, S Lariven, ... European Journal of General Practice 30 (1), 2351811, 2024 | 2 | 2024 |
| Osteoarticular Infections Caused by Erysipelothrix rhusiopathiae: Case Report and Literature Review A Maillard, Y Wakim, O Itani, F Ousser, A Bleibtreu, E Caumes, G Monsel Open Forum Infectious Diseases 8 (10), ofab461, 2021 | 2 | 2021 |
| Acute respiratory failure in adult patients with acute myeloid leukemia D Chean, A Maillard, A Benattia, S Fodil, E Azoulay Expert Review of Respiratory Medicine, 1-12, 2024 | | 2024 |
| Neurofilament light chain levels as an early predictive biomarker of neurotoxicity after CAR T-cell therapy M Larue, A Bouvier, A Maillard, A Cuffel, V Allain, R Ursu, AF Carpentier, ... Journal for Immunotherapy of Cancer 12 (9), e009525, 2024 | | 2024 |
| Penetration of isavuconazole into the epithelial lining fluid of patients with pulmonary fungal infections. Comment on:‘Pharmacokinetics of isavuconazole at different target … A Maillard, L Froelicher Bournaud, J Pastre, B Planquette, P Parize, ... Journal of Antimicrobial Chemotherapy 79 (9), 2403-2405, 2024 | | 2024 |
| Efficacité clinique du Céfiderocol et de l'association Ceftazidime-avibactam/Aztréonam, comparés à la meilleure alternative disponible, dans les infections à bacilles gram … A Gavaud, L Baucher, A Maillard, B Rached, N Loche, H Junot, J Robert, ... Médecine et Maladies Infectieuses Formation 3 (2), S33-S34, 2024 | | 2024 |
